Dr Nick Housby, BSc, MSc, PhD, PGDiP (Strategy and Innovation)

Nick Housby is a specialist in microbial genetics, genomics and biotechnology with experience in technology transfer, new business incubation, and start-up/spinoff creation (Oxagen (Human Genetics, 2003) Novolytics (antimicrobial therapeutics, 2010), BioMimox (peptide aptamers, 2014), Arcamis (business consulting, 2010). He also led the creation of the Molecular Diagnostics Centre within the John Radcliffe Hospital, Oxford and the Oxford Genomics Medicine Centre.

His current positions include: CEO of Accunea Ltd, a medical device company with real-time diagnostic monitoring products for patients with AKI, a Strategic and Commercial Advisor for Capital Cell, a life sciences crowdfunding organisation based in the UK and Spain.

Nick is a current member of the Diagnostics Advisory Council in Oxfordshire.